Osteogenesis imperfecta type 111
DOI:
https://doi.org/10.18203/2349-3291.ijcp20160174Keywords:
Osteogenesis imperfecta type III, Recurrent fractures, BisphosphonatesAbstract
Osteogenesis Imperfecta is a rare inherited disorder affecting connective tissue integrity, characterized by bone fragility of varying severity ranging from lethal forms to those with very minimal features. Here, we are presenting a case of 3 months old infant with multiple fractures sustained during routine handling .Baby was diagnosed as OI type III, which is the most severe non-lethal form of the disease. Early diagnosis and institution of new modalities of treatments like bisphosphonates and surgical stabilization gives better prognosis in these patients.References
Marini JC. Osteogenesis imperfecta. In: Nelson WE, Behrman RE, Kliegman RM, Arvin AM, editors.Nelson Textbook of Pediatrics. 18th ed. Philadelphia: W.B. Saunders Company; 2007:2887–90.
Steiner RD, Adsit J, Basel D. COL1A1/2-Related Osteogenesis Imperfecta. Gene Reviews. 1993-2015.2005 Jan 28 [updated 2013 Feb 14].
Kelley BP, Malfait F, Bonafe L, Baldridge D, Homan E, Symoens S, et al. Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome. J Bone Miner Res. 2011;26(3):666-72.
Starman BJ, Eyre D. Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype. J Clin Invest. 1989;84(4):1206-14.
Oakley I, Reece L. Anesthetic implications for the patient with osteogenesis mperfecta. AANA Journal. 2010;78(1):47-53.
Beattie ML, Kim JW, Gong SG, Murdoch-Kinch CA, Simmer JP, Hu JC. Phenotypic variation in dentinogenesis imperfecta/dentin dysplasia linked to 4q21. J Dent Res. 2006;85(4):329-33.
Pillion JP, Vernick D, Shapiro J. Hearing loss in osteogenesis imperfecta: Characteristics and treatment considerations. Genetics Research International. 2011;2011:1-6.
Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16:101-6.
Roughley PJ, Rauch F, Glorieux FH. Osteogenesis imperfecta - clinical and molecular diversity. European Cells and Materials .2003;5:41-7.
Obafemi AA, Bulas DI, Troendle J, Marini JC. Popcorn calcification in osteogenesis imperfecta: incidence, progression, and molecular correlation. Am J Med Genet A. 2008;146A(21):2725-32.
Shaw NJ. Management of Osteoporosis in children. European Journal of Endocrinology. 2008;159:S33-9.
Nicolao N, Bowe J, Wilkinson J, Bell MJ. Use of the Sheffield Telescopic Intramedullary Rod System for the management of osteogenesis imperfecta. Journal of Bone and Joint Surgery American. 2011;93(21):1994-2000.
Van Dijk FS, Cobben JM, Kariminejad A, Maugeri A, Nikkels PG, van Rijn RR, et al. Osteogenesis Imperfecta: A Review with Clinical Examples. Molecular syndromology.2011;2(1):1-20.
